In addition, it was also noted that TGFBR1 (transforming growth factor-β receptor 1), which is an anti-inflammatory cytokine that inhibits the production of pro-inflammatory cytokines such as IL-6 and TNF-α was found to be up regulated in type 2 diabetes, most probably as a compensatory mechanism. The gene discussed is IL6; the disease is type 2 diabetes mellitus.